---
title: "Chinese Drug Administration Accepts Marketing Application of Huadong Medicine's Unit for Roflumilast Cream; Shares Up 1%"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263939521.md"
description: "Chinese Drug Administration Accepts Marketing Application of Huadong Medicine's Unit for Roflumilast Cream; Shares Up 1%"
datetime: "2025-11-03T04:20:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263939521.md)
  - [en](https://longbridge.com/en/news/263939521.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263939521.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/263939521.md) | [繁體中文](https://longbridge.com/zh-HK/news/263939521.md)


# Chinese Drug Administration Accepts Marketing Application of Huadong Medicine's Unit for Roflumilast Cream; Shares Up 1%



### 相关股票

- [HUADONG MEDICINE (000963.CN)](https://longbridge.com/zh-CN/quote/000963.CN.md)

## 相关资讯与研究

- [Huadong Medicine's Unit Gets Nod for Hypertriglyceridemia Drug Clinical Trial](https://longbridge.com/zh-CN/news/274912733.md)
- [Huadong Medicine Gets U.S. Regulatory Nod for Liver Disease Drug Trial](https://longbridge.com/zh-CN/news/272634618.md)
- [CITIC Securities Offers Guarantee to Unit's $9.8 Million Bond Issuance](https://longbridge.com/zh-CN/news/278658777.md)
- [Huadong Medicine's Two Drugs Placed in China's Insurance Drug List](https://longbridge.com/zh-CN/news/268897142.md)
- [Huadong Medicine Q3 net profit up 7.7% y/y](https://longbridge.com/zh-CN/news/262877878.md)